-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Friday Satellite Symposia

Friday, December 8, 2023

Friday | top

7:00 AM-10:00 AM

Advances in the Treatment Paradigm of Myeloid Malignancies: From Biology to Clinical Practice
Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
BEYOND THE GUIDELINES: Clinical Investigator Perspectives on the Management of Patients with Follicular, Mantle Cell and Hodgkin Lymphoma (Part 1 of a 4-part CME-accredited Symposia Series)
Exploring Unmarked Territory in MDS: Taking Command and Enhancing Care with Team-Based Diagnosis and Treatment for Lower- and Higher-Risk Disease
Medical Crossfire: Novel BTKi Strategies Transforming Aggressive and Indolent B-Cell Malignancies
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific Options

11:00 AM-2:00 PM

A Master Class in Personalized Myelofibrosis Care: Applying New Evidence and Novel Therapeutic Strategies to Improve Outcomes
An MCL Quiz Game: Experts Review New and Emerging Therapies to Optimize Clinical Outcomes
BEYOND THE GUIDELINES: Clinical Investigator Perspectives on the Management of Patients with Diffuse Large B-Cell Lymphoma (Part 2 of a 4-part CME-accredited Symposia Series)
CAR T-Cell Therapies in Relapsed/Refractory Multiple Myeloma: Evaluating the Evidence for Optimal Integration
Controlling and Conquering CLL: Guidance on Modern Targeted Options, Innovative Combinations, and Sequential Management
Experts Address the Hottest Topics in AML: Considerations on FLT3, IDH1/2, TP53, Maintenance, Novel Combinations and Beyond!
Hitting the Mark? Targeted Antibody-Based Therapy for Diffuse Large B-cell Lymphoma
Medical Crossfire: Bridging Expert Guidance and Evidence-Based Recommendations in the Treatment of AYA and Adult ALL
Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?
More Than a Disease: Exploring the Patient Journey for Chronic Immune Thrombocytopenia
Multiple Myeloma: Clinical Challenges for the Community Clinician
Optimizing Myelofibrosis Management With Current and Emerging Therapies
Reimagining Outcomes in Hemophilia: Improving Efficacy and Reducing Treatment Burden with High-Sustained Factor and Non-Factor Replacement Therapies
Show Me the Data: How Do We Navigate the Latest Evidence on Novel Therapies, Combinations, and Clinical Trials Across MPN Care in the Context of Current Treatment Algorithms?
Untangling Amyloidosis 2023: Diagnosis, Prognosis, Selection of Individualized Therapy, and Management of Difficult Clinical Complications

3:00 PM-6:00 PM

Achieving ''Next-Level'' Care in AML: Conversations on Targeted Platforms, Emerging Immunotherapies, and Implications for Precision Medicine
Advances in Autoimmune Hemolytic Anemia: Targeting the Complement Cascade in Cold Agglutinin Disease
Advances in Precision Medicine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Care
Advancing cTTP Care Through Integration of the Latest Clinical Evidence
AL Amyloidosis: Advancements and Future Trends on Diagnosis and Individualized Treatment Approaches
Amplifying New and Emerging Clinical Evidence in the Treatment and Management of Myelodysplastic Syndrome
An Expert Guide to What's New and What''s Next for Novel Targeted Therapies in Relapsed/Refractory Follicular Lymphoma
A Rare Day in the Community Hematology Clinic: Interesting Cases in Classical Hematology
BEYOND THE GUIDELINES: Clinical Investigator Perspectives on the Management of Patients with Chronic Lymphocytic Leukemia (Part 3 of a 4-part CME-accredited Symposia Series)
Case Challenges in Myelofibrosis for the Community Clinician
Changing the Path of Myelofibrosis: Envisioning a Brighter Future for Our Patients
Complement Wheel: Optimizing Care for Patients with aHUS, HSCT-TMA, and PNH
Comprehensive Approaches to Creating Successful Sickle Cell Management Plans Across Patients' Lifespans
Putting Your Stamp on the Next Generation of Care in CML: Improving Outcomes from Frontline to R/R Treatment Settings
Real-World Applications of Asparaginase Formulations in ALL and LBL from Pediatric/AYA to Adult Treatment: Maximizing Clinical Benefits Through Multidisciplinary Care
Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation Agents

7:00 PM-10:00 PM

BEYOND THE GUIDELINES: Clinical Investigator Perspectives on the Management of Patients with Multiple Myeloma (Part 4 of a 4-part CME-accredited Symposia Series)
Evolving Paradigms: Novel Approaches and Best Practices for Hodgkin Lymphoma
How Do We Treat GvHD Today... And Tomorrow? Treatment Algorithms for Key Decision Points in Prophylaxis Care, Acute, and Chronic Disease